Member Exclusive

New drug mediates side effects of stroke treatment

Researchers at Joslin Diabetes Center (Boston, MA, USA) have investigated the utilization of a drug in combination with thrombolytic treatment to potentially improve stroke outcomes.

Go to the profile of Peter Brown
Jan 31, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.